Back to search
ICAS - Intracranial Atherosclerosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which ICAS - Intracranial Atherosclerosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which ICAS - Intracranial Atherosclerosis trials you may qualify forIntracranial atherosclerotic disease is the most common cause of ischemic stroke that is directly attributed to the progression or rupture of intracranial high-…
Intracranial atherosclerotic stenosis (ICAS) is a common cause of stroke, especially in East and South Asia, and is significantly associated with stroke recurre…
The purpose of the study are: 1. To make quality, characterized samples and related data available for future studies, including Genome Wide Association Studie…
Intracranial atherosclerotic stenosis (ICAS) carries substantial stroke risk despite optimal medical treatment. Current risk stratification relies primarily on…
Intracranial atherosclerotic disease is the most common cause of ischemic stroke in Asia, also in China. Currently, despite vascular recanalization therapy, sta…
This study will explore the safety and efficacy of BASIS technology in ICAS-LVO lesions through a multicenter, prospective, registry, observational single-arm s…
The goal of this clinical trial is to learn whether pemafibrate can help prevent worsening of intracranial arterial stenosis (ICAS) in patients who have symptom…
Narrowing of the carotid artery due to atherosclerosis with an unstable plaque can cause a stroke. Patients with carotid artery disease who have had a TIA or mi…
This study is a prospective, multicenter, double-blind, randomized, placebo-controlled clinical trial designed to evaluate whether early administration of PCSK9…